Credit Suisse Healthcare Conference

Size: px
Start display at page:

Download "Credit Suisse Healthcare Conference"

Transcription

1 Credit Suisse Healthcare Conference November 14, 2013

2 Safe Harbor Statement 2 Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: To the extent any statements made in this presentation contain information that is not historical; these statements are forwardlooking in nature and express the beliefs and expectations of management. Such statements are based on current expectations and involve a number of known and unknown risks and uncertainties that could cause the Company s future results, performance, or achievements to differ significantly from the results, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: the effect of current economic conditions on the Company s industry, business, financial position, and results of operations; fluctuations in revenues and operating income; the Company s ability to promptly correct the issues raised in the warning letter and Form 483 observations received from the FDA; the Company s ability to successfully develop and commercialize pharmaceutical products in a timely manner; reductions or loss of business with any significant customer; the impact of consolidation of the Company s customer base; the impact of competition; the Company s ability to sustain profitability and positive cash flows; any delays or unanticipated expenses in connection with the operation of the Company s Taiwan facility; the effect of foreign economic, political, legal, and other risks on the Company s operations abroad; the uncertainty of patent litigation; the increased government scrutiny on the Company s agreements with brand pharmaceutical companies; consumer acceptance and demand for new pharmaceutical products; the impact of market perceptions of the Company and the safety and quality of the Company s products; the difficulty of predicting FDA filings and approvals; the Company s ability to achieve returns on its investments in research and development activities; the Company s inexperience in conducting clinical trials and submitting new drug applications; the Company s ability to successfully conduct clinical trials; the Company s reliance on third parties to conduct clinical trials and testing; impact of illegal distribution and sale by third parties of counterfeits or stolen products; the availability of raw materials and impact of interruptions in the Company s supply chain; the use of controlled substances in the Company s products; disruptions or failures in the Company s information technology systems and network infrastructure; the Company s reliance on alliance and collaboration agreements; the Company s dependence on certain employees; the Company s ability to comply with legal and regulatory requirements governing the healthcare industry; the regulatory environment; the Company s ability to protect its intellectual property; exposure to product liability claims; changes in tax regulations; the Company s ability to manage growth, including through potential acquisitions; the restrictions imposed by the Company s credit facility; uncertainties involved in the preparation of the Company s financial statements; the Company s ability to maintain an effective system of internal control over financial reporting; the effect of terrorist attacks on the Company s business; the location of the Company s manufacturing and research and development facilities near earthquake fault lines and other risks described in the Company s periodic reports filed with the Securities and Exchange Commission. Forwardlooking statements speak only as to the date on which they are made, and the Company undertakes no obligation to update publicly or revise any forward-looking statement, regardless of whether new information becomes available, future developments occur or otherwise. Note: All product sales data included herein are derived from data published by IMS for the 12 months ended September Trademarks referenced herein are the property of their respective owners Impax Laboratories, Inc. All Rights Reserved.

3 Positioned for Future Growth Targeting Sustainable Generic and Specialized Brand Markets Generic pipeline targeting $26B U.S. sales Brand pipeline focused on Central Nervous System (CNS) Solid platform on which to build long-term growth Established Core Competencies Track record of complex formulation and development Established drug delivery capabilities Hatch-Waxman expertise and Paragraph IV successes Strong and Flexible Financial Profile Diversifying Generic business product mix Building a Branded business pipeline Financial resources and flexibility to support growth 3 Note: All brand/generic product sales data included herein are derived from data published by IMS for the 12 months ended September 2013.

4 Two Platforms for Growth Generic Platform Branded Platform Unique targeted ANDAs Solid Oral Dosage (SOD) Alternative Dosage Form (ADF) First-to-File/First-to-Market emphasis Focusing on sustainable products Partnerships/M&A primarily on ADFs 69 products pending at FDA or under development Creating highly valued CNS products RYTARY TM NDA pending approval Commercializing Zomig in the U.S. Partnerships/M&A areas Neurology Psychiatry Building a product pipeline Developing strong IP positions 4 Note: Data as of October 2013.

5 Strategy to Create Long Term Growth Revenue Growth Opportunities Diversifying Generic Business product mix Operational Improvements Focusing on improving quality and compliance Focusing on building a Brand pipeline Right-sizing manufacturing costs and capacity Executing business development and M&A activities Enhancing management team across the company Supported by financial resources and strong balance sheet: approximately $437MM cash/cash equivalents and no debt 5 Note: Data as of September 30, 2013,.

6 Committed to Improving Our Operations Quality first culture Management and organization structure changes Initiated an internal Quality Improvement Program (QIP) Working aggressively to complete key aspects of the QIP Third-party experts continue to assist us with: Review of our manufacturing and quality systems Enhancing our systems and standards Committed to resolving all observations and exceeding current Good Manufacturing Practice 6

7 Strategic Initiatives for Generic Growth Focusing on Organic Growth through SOD and ADF Forms Organic Growth Partnership Mainly in ADF Both Solid Oral & Alternative Dosage Forms (ADF) Strategic Partnerships Primarily in ADFs Strategic M & A M&A Mainly in ADF Primarily in ADFs 7

8 2013 Generic Product Launches 8 January Oxymorphone Hydrochloride ER tablets 5, 7.5, 10, 15, 20, 30 and 40 mg May Authorized generic Zomig tablets Authorized generic Zomig Orally Disintegrating Tablets 2.5 and 5 mg July Authorized generic Trilipix Delayed Release Capsules 45 and 135 mg Shortly Solaraze Gel 3%

9 Diversifying Currently Marketed Portfolio 47 Currently Marketed Products Alternative Dosage Form 19% 9 13 Controlled-Release Solid Oral 28% 25 Other Solid Oral 53% 9 Note: Data as of October 2013.

10 Diversifying Generic Product Pipeline 69 Future Opportunities Pending at FDA or Under Development $26B Current U.S. Brand/Generic Sales Pending at FDA Under Development 19 Total ADF 28% of Pipeline 32 Total C-R SO 46% of Pipeline 18 Total Other SO 26% of Pipeline 10 Note: Date as of October All product sales data included herein are derived from data published by IMS for the 12 months ended September 2013.

11 Strategic Initiatives for Brand Growth Focusing on Organic Growth through SOD and ADF Forms Organic Growth Partnership Mainly in ADF Primarily in Neurology Area Partnerships Neurology & Psychiatry Areas M & A M&A Mainly in ADF Neurology & Psychiatry Areas (Products/Companies) 11

12 Building a Brand Product Pipeline PROJECT Zomig RYTARYTM (a) IPX203 IPX231 IPX232 IPX PHASE I OR POC PHASE II PHASE III REGISTRATION APPROVED Migraine Parkinson s Disease (carbidopa-levodopa) Parkinson s Disease Parkinson s Disease Migraine Exploratory Projects (a) On Jan. 21, 2013, the Company announced the receipt of a complete response letter from the FDA indicating that the FDA required a satisfactory re-inspection of the Company s Hayward manufacturing facility before the RYTARY NDA may be approved. On March 4, 2013, the Company announced the receipt of a Form 483 following an inspection of Hayward that may hold up approval of RYTARY TM, as analytical method validation and a portion of the stability data were generated at the Hayward facility. 12

13 RYTARY TM (IPX066): Carbidopa and Levodopa Extended-Release Capsule PATENT INFORMATION DEC FEB JAN. 21, 2013 (a) THROUGHOUT 2013 RYTARY (IPX066) for the Symptomatic Treatment of Parkinson s Disease 1st Patent Granted Aug Expires May nd Patent Granted Dec Expires Dec NDA Filed FDA Acceptance of NDA Filing PDUFA Date - Received Complete Response Letter Pre-launch planning More than one million people in the U.S., with 50,000-60,000 new cases diagnosed each year in the U.S. alone 13 (a) On Jan. 21, 2013, the Company announced the receipt of a complete response letter from the FDA indicating that the FDA required a satisfactory re-inspection of the Company s Hayward manufacturing facility before the RYTARY TM NDA may be approved. On March 4, 2013, the Company announced the receipt of a Form 483 following an inspection of Hayward that may hold up approval of RYTARY TM, as analytical method validation and a portion of the stability data were generated at the Hayward facility. Source: National Parkinson s Foundation. Parkinson s Disease Overview

14 Continuing Our Commercial Success Building relationships with neurologists since July 2006 Licensed exclusive U.S. commercialization rights to Zomig Began commercializing Zomig in April 2012 o Tablet and ZMT patents expired May 2013 Continuing commercialization of Zomig Nasal Spray o Nasal Spray patent expires May 2021 Nasal Triptan Market Share, National 80% 70% 60% 50% 40% 30% 20% 10% 0% Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 May-13 Jun-13 Jul-13 Aug-13 Sep-13 Since Impax Promotion April 12 to Sept. 13 Sumatriptan -5% decrease Zomig +17% increase Imitrex -7% decrease 14 Source: IMS NPA Weekly

15 Positioned for Future Growth Targeting Sustainable Generic and Specialized Brand Markets Generic pipeline targeting $26B U.S. sales Brand pipeline focused on Central Nervous System (CNS) Solid platform on which to build long-term growth Established Core Competencies Track record of complex formulation and development Established drug delivery capabilities Hatch-Waxman expertise and Paragraph IV successes Strong and Flexible Financial Profile Diversifying Generic business product mix Building a Branded business pipeline Financial resources and flexibility to support growth 15 Note: All brand/generic product sales data included herein are derived from data published by IMS for the 12 months ended September 2013.

HOSPIRA (HSP US) HISTORICAL COMMON STOCK PRICE INFORMATION

HOSPIRA (HSP US) HISTORICAL COMMON STOCK PRICE INFORMATION 30-Apr-2004 28.35 29.00 28.20 28.46 28.55 03-May-2004 28.50 28.70 26.80 27.04 27.21 04-May-2004 26.90 26.99 26.00 26.00 26.38 05-May-2004 26.05 26.69 26.00 26.35 26.34 06-May-2004 26.31 26.35 26.05 26.26

More information

Median and Average Sales Prices of New Homes Sold in United States

Median and Average Sales Prices of New Homes Sold in United States Jan 1963 $17,200 (NA) Feb 1963 $17,700 (NA) Mar 1963 $18,200 (NA) Apr 1963 $18,200 (NA) May 1963 $17,500 (NA) Jun 1963 $18,000 (NA) Jul 1963 $18,400 (NA) Aug 1963 $17,800 (NA) Sep 1963 $17,900 (NA) Oct

More information

THE UNIVERSITY OF BOLTON

THE UNIVERSITY OF BOLTON JANUARY Jan 1 6.44 8.24 12.23 2.17 4.06 5.46 Jan 2 6.44 8.24 12.24 2.20 4.07 5.47 Jan 3 6.44 8.24 12.24 2.21 4.08 5.48 Jan 4 6.44 8.24 12.25 2.22 4.09 5.49 Jan 5 6.43 8.23 12.25 2.24 4.10 5.50 Jan 6 6.43

More information

The Future of Consumer Health Care

The Future of Consumer Health Care The Future of Consumer Health Care Coming Together To Lead The Consumer Health Care Industry 2 Creating a New Business Model in Consumer Health Care 3 Serve More Consumers In More Parts of the World, More

More information

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015

AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network

More information

NAV HISTORY OF DBH FIRST MUTUAL FUND (DBH1STMF)

NAV HISTORY OF DBH FIRST MUTUAL FUND (DBH1STMF) NAV HISTORY OF DBH FIRST MUTUAL FUND () Date NAV 11-Aug-16 10.68 8.66 0.38% -0.07% 0.45% 3.81% 04-Aug-16 10.64 8.66-0.19% 0.87% -1.05% 3.76% 28-Jul-16 10.66 8.59 0.00% -0.34% 0.34% 3.89% 21-Jul-16 10.66

More information

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS* COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun

More information

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*

COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS* COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun

More information

Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138. Exhibit 8

Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138. Exhibit 8 Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 1 of 138 Exhibit 8 Case 2:08-cv-02463-ABC-E Document 1-4 Filed 04/15/2008 Page 2 of 138 Domain Name: CELLULARVERISON.COM Updated Date: 12-dec-2007

More information

ANNEXURE 1 STATUS OF 518 DEMAT REQUESTS PENDING WITH NSDL

ANNEXURE 1 STATUS OF 518 DEMAT REQUESTS PENDING WITH NSDL ANNEXURE 1 STATUS OF 518 DEMAT REQUESTS PENDING WITH NSDL Sr. No. Demat Request No.(DRN) DP ID Client ID Date of Demat Request Received Quantity Requested Date of Demat Request Processed No. of days of

More information

Flamel Technologies Provides Update on Corporate Progress

Flamel Technologies Provides Update on Corporate Progress Flamel Technologies Provides Update on Corporate Progress Clinical Programs Continue to Move Forward Outlines Full Year 2016 Revenue Guidance Lyon, France January 8, 2016 - Flamel Technologies (NASDAQ:

More information

Analysis One Code Desc. Transaction Amount. Fiscal Period

Analysis One Code Desc. Transaction Amount. Fiscal Period Analysis One Code Desc Transaction Amount Fiscal Period 57.63 Oct-12 12.13 Oct-12-38.90 Oct-12-773.00 Oct-12-800.00 Oct-12-187.00 Oct-12-82.00 Oct-12-82.00 Oct-12-110.00 Oct-12-1115.25 Oct-12-71.00 Oct-12-41.00

More information

Flamel Technologies Announces Second Quarter Results of Fiscal Year 2015

Flamel Technologies Announces Second Quarter Results of Fiscal Year 2015 Flamel Technologies Announces Second Quarter Results of Fiscal Year 2015 Product revenue guidance for 2015 of $170-$185 million reaffirmed Conference call with management to take place at 10:00 am ET on

More information

Successfully Scaling an Agile Innovation Culture with Perforce

Successfully Scaling an Agile Innovation Culture with Perforce Successfully Scaling an Agile Innovation Culture with Perforce Steve Greene VP, Program Management Salesforce.com Mike Saha Sr. Manager, Release Engineering Salesforce.com Safe Harbor Safe harbor statement

More information

NASDAQ: ATRS. Bank of America Merrill Lynch 2015 Health Care Conference May 13, 2015

NASDAQ: ATRS. Bank of America Merrill Lynch 2015 Health Care Conference May 13, 2015 NASDAQ: ATRS Bank of America Merrill Lynch 2015 Health Care Conference May 13, 2015 Safe Harbor Statement This presentation may contain forward-looking statements which are made pursuant to the safe harbor

More information

Enhanced Vessel Traffic Management System Booking Slots Available and Vessels Booked per Day From 12-JAN-2016 To 30-JUN-2017

Enhanced Vessel Traffic Management System Booking Slots Available and Vessels Booked per Day From 12-JAN-2016 To 30-JUN-2017 From -JAN- To -JUN- -JAN- VIRP Page Period Period Period -JAN- 8 -JAN- 8 9 -JAN- 8 8 -JAN- -JAN- -JAN- 8-JAN- 9-JAN- -JAN- -JAN- -JAN- -JAN- -JAN- -JAN- -JAN- -JAN- 8-JAN- 9-JAN- -JAN- -JAN- -FEB- : days

More information

COE BIDDING RESULTS 2009 Category B Cars >1600 cc

COE BIDDING RESULTS 2009 Category B Cars >1600 cc Quota System A COE BIDDING RESULTS 2009 B Jan-2009 Quota 1,839 1,839 1,100 1,099 274 268 409 411 767 758 Successful bids 1,784 1,832 1,100 1,097 274 260 401 386 763 748 Bids received 2,541 2,109 1,332

More information

Disclaimer: Forward Looking Statements

Disclaimer: Forward Looking Statements Disclaimer: Forward Looking Statements This presentation/announcement may contain forward looking statements with projections regarding, among other things, the Company s strategy, revenues, earnings,

More information

First to File and Beyond: Paragraph IV Business Strategies

First to File and Beyond: Paragraph IV Business Strategies First to File and Beyond: Paragraph IV Business Strategies THOMSON REUTERS INTELLECTUAL PROPERTY & SCIENCE GENERICS & API INTELLIGENCE Benjamin Burck Research Analyst and Project Manager Generics & API

More information

Third-Quarter 2015 Earnings Call. October 29, 2015

Third-Quarter 2015 Earnings Call. October 29, 2015 Third-Quarter 2015 Earnings Call October 29, 2015 Safe Harbor statement Certain statements made in this presentation contain forward-looking statements within the meaning of Section 27A of the Securities

More information

S&P Year Rolling Period Total Returns

S&P Year Rolling Period Total Returns S&P 500 10 Year Rolling Period Total Returns Summary: 1926 June 2013 700% 600% 500% 400% 300% 200% 100% 0% 100% Scatter chart of all 931 ten year periods. There were 931 ten year rolling periods from January

More information

Matthew Emmens CEO Shire plc

Matthew Emmens CEO Shire plc Goldman Sachs 28 th Annual Global Healthcare Conference June 13, 2007 Matthew Emmens CEO Shire plc THE SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995 Statements included

More information

Goldman Sachs Conference. 22 May 2014 1

Goldman Sachs Conference. 22 May 2014 1 Goldman Sachs Conference 22 May 2014 1 Delivering growth in shareholder returns BoB Internet and phone in one. Launches Mobile services Launches Fetch TV services First ISP to offer NBN services BoB2 Launches

More information

FORM 6-K. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549. Report of Foreign Private Issuer

FORM 6-K. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549. Report of Foreign Private Issuer FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 For the month of August 2011

More information

Investor science conference call: American College of Cardiology 2015

Investor science conference call: American College of Cardiology 2015 Investor science conference call: American College of Cardiology 2015 San Diego, California, USA 16 March 2015 Cautionary statement regarding forward-looking statements In order, among other things, to

More information

Q3 2015 Financial Results and Corporate Update. November 4, 2015

Q3 2015 Financial Results and Corporate Update. November 4, 2015 Q3 2015 Financial Results and Corporate Update November 4, 2015 Introductions and Forward- Looking Statements Silvia Taylor, SVP Investor Relations and Corporate Affairs Agenda Introductions and Forward-Looking

More information

China Pharma Holdings, Inc. Reports Second Quarter 2010 Financial Results

China Pharma Holdings, Inc. Reports Second Quarter 2010 Financial Results China Pharma Holdings, Inc. Reports Second Quarter 2010 Financial Results HAIKOU CITY, China, August 10, 2010 China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ( China Pharma or the Company ), a leading fully

More information

Dr. Reddy s Q3 and 9M FY16 Financial Results

Dr. Reddy s Q3 and 9M FY16 Financial Results Press Release DR. REDDY'S LABORATORIES LTD. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500034. Telangana, India. INVESTOR RELATIONS KEDAR UPADHYE kedaru@drreddys.com (Ph: +91-40-66834297) CONTACT

More information

Q1 2010 Results Analyst Presentation Henk van Dalen, CFO 3 May 2010

Q1 2010 Results Analyst Presentation Henk van Dalen, CFO 3 May 2010 Q1 2010 Results Analyst Presentation Henk van Dalen, CFO 3 May 2010 Overall trading conditions continue to improve GROUP Operating income 251 million ( 163 million in Q1 20); quarter benefited from four

More information

Western Union. Scott Scheirman, EVP and CFO. March 11, 2013

Western Union. Scott Scheirman, EVP and CFO. March 11, 2013 Western Union Scott Scheirman, EVP and CFO March 11, 2013 SAFE HARBOR This presentation contains certain statements that are forward-looking within the meaning of the Private Securities Litigation Reform

More information

RIIO-T1 business plan submission London Tuesday 6 September 2011

RIIO-T1 business plan submission London Tuesday 6 September 2011 RIIO-T1 business plan submission London Tuesday 6 September 2011 Cautionary statement This presentation contains certain statements that are neither reported financial results nor other historical information.

More information

Annual Shareholder Meeting. June 2012

Annual Shareholder Meeting. June 2012 Annual Shareholder Meeting June 2012 Agenda Call to Order; Opening of Polls Introduction of Directors Introduction of Management Introduction of Independent Registered Public Accounting Firm Designation

More information

A World Leading Addiction Treatment Company with enormous future potential. Jefferies Healthcare Conference 2014

A World Leading Addiction Treatment Company with enormous future potential. Jefferies Healthcare Conference 2014 A World Leading Addiction Treatment Company with enormous future potential Jefferies Healthcare Conference 2014 Disclaimer. For the purposes of this disclaimer the "Presentation" shall mean and include

More information

Financial results for the first quarter 2003

Financial results for the first quarter 2003 Financial results for the first quarter 2003 1 Forward looking statements 2 Certain statements in this report that are neither reported financial results nor other historical information, are forward-looking

More information

IntercontinentalExchange. Credit Suisse Financial Services Forum February 7, 2008

IntercontinentalExchange. Credit Suisse Financial Services Forum February 7, 2008 IntercontinentalExchange Credit Suisse Financial Services Forum February 7, 2008 Forward-Looking Statements Forward-Looking Statements This presentation may contain forward-looking statements made pursuant

More information

TECO Energy Edison Electric Institute Financial Conference

TECO Energy Edison Electric Institute Financial Conference TECO Energy Edison Electric Institute Financial Conference Dallas, TX Nov. 13, 2014 Forward Looking Statements The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking

More information

November Investor Presentation

November Investor Presentation November 2015 Investor Presentation Safe Harbor Statement The following presentation includes forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation

More information

2009 First Quarter Results Presentation

2009 First Quarter Results Presentation 2009 First Quarter Results Presentation February 17, 2009 Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the safe harbor provisions of the

More information

P/T 2B: 2 nd Half of Term (8 weeks) Start: 24-AUG-2015 End: 18-OCT-2015 Start: 19-OCT-2015 End: 13-DEC-2015

P/T 2B: 2 nd Half of Term (8 weeks) Start: 24-AUG-2015 End: 18-OCT-2015 Start: 19-OCT-2015 End: 13-DEC-2015 2015-2016 SPECIAL TERM ACADEMIC CALENDAR For Scranton Education Online (SEOL), Masters of Business Administration Online, Masters of Accountancy Online, Health Administration Online, Health Informatics

More information

SPAR NORD ANNOUNCES CONDITIONAL PUBLIC OFFER FOR SHARES IN NØRRESUNDBY BANK A/S. Investor and analyst briefing, 10 November 2014

SPAR NORD ANNOUNCES CONDITIONAL PUBLIC OFFER FOR SHARES IN NØRRESUNDBY BANK A/S. Investor and analyst briefing, 10 November 2014 SPAR NORD ANNOUNCES CONDITIONAL PUBLIC OFFER FOR SHARES IN NØRRESUNDBY BANK A/S Investor and analyst briefing, 0 November 204 DISCLAIMER The information contained in this presentation shall not constitute

More information

XENOPORT INC FORM 8-K. (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14

XENOPORT INC FORM 8-K. (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14 XENOPORT INC FORM 8-K (Current report filing) Filed 05/08/14 for the Period Ending 05/08/14 Address 3410 CENTRAL EXPRESSWAY SANTA CLARA, CA 95051 Telephone 4086167200 CIK 0001130591 Symbol XNPT SIC Code

More information

Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED

Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED Comprehensive Medical Waste and Unused Medication Management Solutions Provider NASDAQ: SMED INVESTOR PRESENTATION NOVEMBER Safe Harbor These slides contain (and the accompanying oral discussion will contain)

More information

IntercontinentalExchange Fourth Quarter & Year-End 2008. Earnings Presentation February 10, 2009

IntercontinentalExchange Fourth Quarter & Year-End 2008. Earnings Presentation February 10, 2009 IntercontinentalExchange Fourth Quarter & Year-End 20 Earnings Presentation February 10, 2009 Forward-Looking Statements Forward-Looking Statements This presentation may contain forward-looking statements

More information

Acrux (ASX: ACR) 28 April 2014

Acrux (ASX: ACR) 28 April 2014 Acrux (ASX: ACR) 28 April 2014 FORWARD-LOOKING STATEMENTS 2 This presentation includes forward-looking statements that are subject to risks and uncertainties. Such statements involve known and unknown

More information

Höegh LNG Partners LP. Höegh LNG Partners LP Fourth Quarter Financial Results February 26, 2015

Höegh LNG Partners LP. Höegh LNG Partners LP Fourth Quarter Financial Results February 26, 2015 Höegh LNG Partners LP Höegh LNG Partners LP Fourth Quarter Financial Results February 26, 2015 Forward-Looking Statements This presentation contains certain forward-looking statements concerning future

More information

Ashley Institute of Training Schedule of VET Tuition Fees 2015

Ashley Institute of Training Schedule of VET Tuition Fees 2015 Ashley Institute of Training Schedule of VET Fees Year of Study Group ID:DECE15G1 Total Course Fees $ 12,000 29-Aug- 17-Oct- 50 14-Sep- 0.167 blended various $2,000 CHC02 Best practice 24-Oct- 12-Dec-

More information

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16

RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS. Earnings Presentation Q2 FY16 RAJESH EXPORTS LIMITED GLOBAL PRESENCE IN GOLD AND GOLD PRODUCTS Earnings Presentation Q2 FY16 Company Overview COMPANY OVERVIEW Rajesh Exports Ltd. (REL) was incorporated in 1989. Currently REL is a leader

More information

RESEARCH IN MOTION REPORTS SECOND QUARTER RESULTS

RESEARCH IN MOTION REPORTS SECOND QUARTER RESULTS FOR IMMEDIATE RELEASE September 16, RESEARCH IN MOTION REPORTS SECOND QUARTER RESULTS Waterloo, ON Research In Motion Limited (RIM) (Nasdaq: RIMM; TSX: RIM), a world leader in the mobile communications

More information

First Quarter Fiscal 2010 Results Presentation

First Quarter Fiscal 2010 Results Presentation First Quarter Fiscal 2010 Results Presentation March 2, 2010 Safe Harbor Statement This announcement contains forward-looking statements. These statements are made under the safe harbor provisions of the

More information

Thomas Hinchliffe, Pharm.D. CDR, U.S. Public Health Service Special Assistant to the Director Office of Generic Drugs Food and Drug Administration

Thomas Hinchliffe, Pharm.D. CDR, U.S. Public Health Service Special Assistant to the Director Office of Generic Drugs Food and Drug Administration Thomas Hinchliffe, Pharm.D. CDR, U.S. Public Health Service Special Assistant to the Director Office of Generic Drugs Food and Drug Administration Disclaimer & Disclosure Views presented are those of the

More information

Profitability & Growth in 2006: Corporate Overview

Profitability & Growth in 2006: Corporate Overview Profitability & Growth in 2006: Corporate Overview April 2006 Certain statements in this presentation may constitute forward looking statements within the meaning of the Private Securities Litigation Reform

More information

Unilever Q Results Graeme Pitkethly / Andrew Stephen April 14 th 2016

Unilever Q Results Graeme Pitkethly / Andrew Stephen April 14 th 2016 Unilever Q1 2016 Results Graeme Pitkethly / Andrew Stephen April 14 th 2016 SAFE HARBOUR STATEMENT This announcement may contain forward-looking statements, including forward-looking statements within

More information

Third Quarter Fiscal 2012 Results Presentation. Aug 16, 2012

Third Quarter Fiscal 2012 Results Presentation. Aug 16, 2012 Third Quarter Fiscal 2012 Results Presentation Aug 16, 2012 Safe Harbor Statement This presentation contains forward-looking statements. These statements are made under the safe harbor provisions of the

More information

Q1 2014 RESULTS CONFERENCE CALL MAY 7, 2014

Q1 2014 RESULTS CONFERENCE CALL MAY 7, 2014 Q1 2014 RESULTS CONFERENCE CALL MAY 7, 2014 CAUTIONARY STATEMENT This presentation may include certain statements that may be deemed to be forward-looking statements within the meaning of the U.S. Private

More information

P/T 2B: 2 nd Half of Term (8 weeks) Start: 25-AUG-2014 End: 19-OCT-2014 Start: 20-OCT-2014 End: 14-DEC-2014

P/T 2B: 2 nd Half of Term (8 weeks) Start: 25-AUG-2014 End: 19-OCT-2014 Start: 20-OCT-2014 End: 14-DEC-2014 2014-2015 SPECIAL TERM ACADEMIC CALENDAR FOR SCRANTON EDUCATION ONLINE (SEOL), MBA ONLINE, HUMAN RESOURCES ONLINE, NURSE ANESTHESIA and ERP PROGRAMS SPECIAL FALL 2014 TERM Key: P/T = Part of Term P/T Description

More information

P/T 2B: 2 nd Half of Term (8 weeks) Start: 26-AUG-2013 End: 20-OCT-2013 Start: 21-OCT-2013 End: 15-DEC-2013

P/T 2B: 2 nd Half of Term (8 weeks) Start: 26-AUG-2013 End: 20-OCT-2013 Start: 21-OCT-2013 End: 15-DEC-2013 2013-2014 SPECIAL TERM ACADEMIC CALENDAR FOR SCRANTON EDUCATION ONLINE (SEOL), MBA ONLINE, HUMAN RESOURCES ONLINE, NURSE ANESTHESIA and ERP PROGRAMS SPECIAL FALL 2013 TERM Key: P/T = Part of Term P/T Description

More information

Second Quarter 2015 Trading Update. 28 September 2015

Second Quarter 2015 Trading Update. 28 September 2015 Second Quarter 2015 Trading Update 28 September 2015 Disclaimer This communication and the information contained herein has been approved by the Board of Directors of Eurobank Ergasias S.A. ( Eurobank

More information

BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability

BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability NEWS RELEASE FOR IMMEDIATE RELEASE June 19, BlackBerry Reports 2015 Fiscal First Quarter GAAP Profitability Waterloo, ON BlackBerry Limited (NASDAQ: BBRY; TSX: BB), a global leader in mobile communications,

More information

Western Union. Khalid Fellahi, SVP & GM WU Digital. March 25, 2014

Western Union. Khalid Fellahi, SVP & GM WU Digital. March 25, 2014 Western Union Khalid Fellahi, SVP & GM WU Digital March 25, 2014 SAFE HARBOR This presentation contains certain statements that are forward-looking within the meaning of the Private Securities Litigation

More information

www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in retail

www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in retail www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in retail Results from PwC s Global Data & Analytics Survey 2014 retail Showrooming and mobile search.

More information

W. R. Grace & Co. Settlement of PI Trust Deferred Payment Obligations

W. R. Grace & Co. Settlement of PI Trust Deferred Payment Obligations W. R. Grace & Co. Settlement of PI Trust Deferred Payment Obligations August 4, 2014 Disclaimer Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 This presentation contains

More information

Forward Looking Statement

Forward Looking Statement Forward Looking Statement This presentation contains forward-looking statements which are statements that refer to expectations and plans for the future and include, without limitation, statements regarding

More information

www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in manufacturing

www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in manufacturing www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in manufacturing Results from PwC s Global Data & Analytics Survey 2014 manufacturing Raw material supply

More information

Fourth Quarter And Fiscal 2012 Results Presentation. Nov 28, 2012

Fourth Quarter And Fiscal 2012 Results Presentation. Nov 28, 2012 Fourth Quarter And Fiscal 2012 Results Presentation Nov 28, 2012 Safe Harbor Statement This presentation contains forward-looking statements. These statements are made under the safe harbor provisions

More information

CENTERPOINT ENERGY TEXARKANA SERVICE AREA GAS SUPPLY RATE (GSR) JULY 2015. Small Commercial Service (SCS-1) GSR

CENTERPOINT ENERGY TEXARKANA SERVICE AREA GAS SUPPLY RATE (GSR) JULY 2015. Small Commercial Service (SCS-1) GSR JULY 2015 Area (RS-1) GSR GSR (LCS-1) Texarkana Incorporated July-15 $0.50690/Ccf $0.45450/Ccf $0.00000/Ccf $2.85090/MMBtu $17.52070/MMBtu Texarkana Unincorporated July-15 $0.56370/Ccf $0.26110/Ccf $1.66900/Ccf

More information

N a s d a q : I N S Y

N a s d a q : I N S Y N a s d a q : I N S Y Michael L. Babich, President and Chief Executive Officer Darryl S. Baker, Chief Financial Officer Jeffries Healthcare Conference, June 2014 Safe Harbor Statement This presentation

More information

Pharmacy Medical Necessity Guidelines: Migraine Medications

Pharmacy Medical Necessity Guidelines: Migraine Medications Pharmacy Medical Necessity Guidelines: Effective: July 18, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy (RX) or Medical (MED) Benefit

More information

Credit Suisse Global Health Care Conference. March 5, 2013

Credit Suisse Global Health Care Conference. March 5, 2013 Credit Suisse Global Health Care Conference March 5, 2013 Safe Harbor Statement This presentation contains forward-looking statements that are subject to various risks and uncertainties. Future results

More information

A LEADING GLOBAL HEALTH CARE GROUP. Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors

A LEADING GLOBAL HEALTH CARE GROUP. Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors A LEADING GLOBAL HEALTH CARE GROUP Frankfurt Stock Exchange (DAX30): FRE US ADR program (OTC): FSNUY wwww.fresenius.com/investors SAFE HARBOR STATEMENT This presentation contains forward-looking statements

More information

PRESS RELEASE Noida, Tuesday, February 9, 2016 Jubilant Life Sciences Ltd. 1A, Sector 16A, Noida 201301, India Tel.: +91 120 4361000 http://www.jubl.com JUBILANT LIFE SCIENCES Q3 & 9M FY2016 RESULTS JUBILANT

More information

AT&T to Acquire DIRECTV May 19, 2014

AT&T to Acquire DIRECTV May 19, 2014 AT&T to Acquire DIRECTV May 19, 2014 2014 AT&T Intellectual Property. All rights reserved. AT&T, the AT&T logo and all other marks contained herein are trademarks of AT&T Intellectual Property and/or AT&T

More information

Flamel Technologies Acquires FSC Pediatrics

Flamel Technologies Acquires FSC Pediatrics Flamel Technologies Acquires FSC Pediatrics Diversifies product portfolio and brings established commercial infrastructure Revised full year 2016 revenue guidance of $110 to $130 million Conference call

More information

Antares Pharma, Inc. Princeton South Corporate Center 100 Princeton South, Suite 300 Ewing, NJ 08628 NASDAQ : ATRS. Paul

Antares Pharma, Inc. Princeton South Corporate Center 100 Princeton South, Suite 300 Ewing, NJ 08628 NASDAQ : ATRS. Paul Antares Pharma, Inc. Princeton South Corporate Center 100 Princeton South, Suite 300 Ewing, NJ 08628 NASDAQ : ATRS Paul Antares Mission: To develop and commercialize self-administered parenteral medicines

More information

Committee of the Whole. January 22, 2014

Committee of the Whole. January 22, 2014 Committee of the Whole January 22, 2014 Drivers for 2003 IT Outsourcing Cost savings - privatization model ($2- $3MM/year) Cost avoidance Data center lease with County expiring ($3.5MM) Disaster recovery

More information

CAFIS REPORT 2015.10

CAFIS REPORT 2015.10 CAFIS REPORT 2015.10 INDEX Message CAFIS Inbound 03-06 07-08 CAFIS Arch 09-10 CAFIS Brain 11-12 CAFIS Global 13-14 What We Do 15-16 About CAFIS 17-18 Services for Member Stores 19-34 Services for Card

More information

Postmedia Network Canada Corp. Q2 F2012 Investor and Analyst Conference Call. April 12, 2012

Postmedia Network Canada Corp. Q2 F2012 Investor and Analyst Conference Call. April 12, 2012 Postmedia Network Canada Corp. Q2 F2012 Investor and Analyst Conference Call April 12, 2012 2 Forward-Looking Statements This presentation may include certain information that is forward-looking information

More information

Legislative Brief: PAY OR PLAY PENALTIES LOOK BACK MEASUREMENT METHOD EXAMPLES. EmPowerHR

Legislative Brief: PAY OR PLAY PENALTIES LOOK BACK MEASUREMENT METHOD EXAMPLES. EmPowerHR EmPowerHR Legislative Brief: PAY OR PLAY PENALTIES LOOK BACK MEASUREMENT METHOD EXAMPLES The Affordable Care Act (ACA) imposes a penalty on applicable large employers (ALEs) that do not offer health insurance

More information

Challenging quarter for Mobile Devices. Daily order rates improving. Free Cash Flow > Net Income. FCT acquisition. Page 3

Challenging quarter for Mobile Devices. Daily order rates improving. Free Cash Flow > Net Income. FCT acquisition. Page 3 August 7, 2013 Page 1 Statements in this release that are not historical are forward-looking and are subject to various risks and uncertainties that could cause actual results to vary materially from those

More information

SunGard Announces Third Quarter 2006 Results

SunGard Announces Third Quarter 2006 Results For more information, contact: Michael Ruane Eric Erickson Kris Block Tel: 484-582-5405 Tel: 484-582-5480 Tel: 484-582-5505 michael.ruane@sungard.com eric.erickson@sungard.com kris.block@sungard.com SunGard

More information

Brookfield Property Partners Offer to Purchase Any or All Issued and Outstanding Common Shares of Brookfield Office Properties Inc.

Brookfield Property Partners Offer to Purchase Any or All Issued and Outstanding Common Shares of Brookfield Office Properties Inc. Brookfield Property Partners Offer to Purchase Any or All Issued and Outstanding Common Shares of Brookfield Office Properties Inc. Shareholder Q&A Brookfield Property Partners L.P. ( Brookfield Property

More information

Regal Beloit Corporation Third Quarter 2014 Earnings Conference Call

Regal Beloit Corporation Third Quarter 2014 Earnings Conference Call Regal Beloit Corporation Third Quarter 2014 Earnings Conference Call November 4, 2014 Mark Gliebe Chairman and Chief Executive Officer Jon Schlemmer Chief Operating Officer Chuck Hinrichs Vice President

More information

Nokia Conference Call 2Q 2012 Financial Results

Nokia Conference Call 2Q 2012 Financial Results Nokia Conference Call 2Q 2012 Financial Results July 19, 2012 15.00 Helsinki time 8.00 New York time Stephen Elop President & CEO Timo Ihamuotila CFO Matt Shimao Head of Investor Relations 1 Disclaimer

More information

CATAMARAN CORPORATION ANNOUNCES RECORD FINANCIAL RESULTS FOR 2014 CATAMARAN TO ACQUIRE HEALTHCARE SOLUTIONS, INC.

CATAMARAN CORPORATION ANNOUNCES RECORD FINANCIAL RESULTS FOR 2014 CATAMARAN TO ACQUIRE HEALTHCARE SOLUTIONS, INC. CATAMARAN CORPORATION ANNOUNCES RECORD FINANCIAL RESULTS FOR 2014 CATAMARAN TO ACQUIRE HEALTHCARE SOLUTIONS, INC. Schaumburg, Illinois, February 26, 2015 - Catamaran Corporation ( Catamaran or the Company

More information

Share Trading Policy. Incitec Pivot Limited ABN 42 004 080 264 70 Southbank Boulevard Southbank Victoria 3006 Australia V1 20.07.06 / 21.12.

Share Trading Policy. Incitec Pivot Limited ABN 42 004 080 264 70 Southbank Boulevard Southbank Victoria 3006 Australia V1 20.07.06 / 21.12. Share Trading Policy Incitec Pivot Limited ABN 42 004 080 264 70 Southbank Boulevard Southbank Victoria 3006 Australia V1 20.07.06 / 21.12.10 Contents 1 Introduction and Purpose 3 2 Who does this policy

More information

www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in healthcare

www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in healthcare www.pwc.com/bigdecisions Are you prepared to make the decisions that matter most? Decision making in healthcare Results from PwC s Global Data & Analytics Survey 2014 healthcare Patient data. Precision

More information

NATIONAL CREDIT UNION SHARE INSURANCE FUND

NATIONAL CREDIT UNION SHARE INSURANCE FUND NATIONAL CREDIT UNION SHARE INSURANCE FUND PRELIMINARY & UNAUDITED FINANCIAL HIGHLIGHTS RENDELL L. JONES CHIEF FINANCIAL OFFICER MANAGEMENT OVERVIEW Balance Sheet Other - Insurance and Guarantee Program

More information

NTREIS MLS Area Housing Activity Report Compiled for North Texas Real Estate Information System. Current Month Summary for: July 2016

NTREIS MLS Area Housing Activity Report Compiled for North Texas Real Estate Information System. Current Month Summary for: July 2016 Use PDF Bookmarks for direct link to report tables. NTREIS MLS Area Housing Activity Report Compiled for North Texas Real Estate Information System Current Month Summary for: July 2016 Property Type Sales

More information

U.S. Credit Card. Trends, Liquidation and Portfolio Pricing

U.S. Credit Card. Trends, Liquidation and Portfolio Pricing U.S. Credit Card Sector Update: Market Trends, Liquidation and Portfolio Pricing Agenda U.S. Credit Card Sector AY Year in Review Key Economic Trends Liquidation and Pricing Changes Market Trends Unfolding

More information

Sale of Red Lobster SPRING 2014

Sale of Red Lobster SPRING 2014 Sale of Red Lobster SPRING 2014 2 Forward-Looking Statement During the course of this presentation, Darden Restaurants officers and employees may make forward-looking statements concerning the Company

More information

RESEARCH IN MOTION REPORTS YEAR-END AND FOURTH QUARTER RESULTS FOR FISCAL 2010

RESEARCH IN MOTION REPORTS YEAR-END AND FOURTH QUARTER RESULTS FOR FISCAL 2010 FOR IMMEDIATE RELEASE March 31, 2010 RESEARCH IN MOTION REPORTS YEAR-END AND FOURTH QUARTER RESULTS FOR FISCAL 2010 Waterloo, ON Research In Motion Limited (RIM) (Nasdaq: RIMM; TSX: RIM), a world leader

More information

Regal Beloit Corporation Second Quarter 2014 Earnings Conference Call

Regal Beloit Corporation Second Quarter 2014 Earnings Conference Call Regal Beloit Corporation Second Quarter 2014 Earnings Conference Call July 30, 2014 Mark Gliebe Chairman and Chief Executive Officer Jon Schlemmer Chief Operating Officer Chuck Hinrichs Vice President

More information

RESEARCH IN MOTION REPORTS FOURTH QUARTER AND YEAR-END RESULTS FOR FISCAL 2009

RESEARCH IN MOTION REPORTS FOURTH QUARTER AND YEAR-END RESULTS FOR FISCAL 2009 FOR IMMEDIATE RELEASE April 2, 2009 RESEARCH IN MOTION REPORTS FOURTH QUARTER AND YEAR-END RESULTS FOR FISCAL 2009 Waterloo, Ontario Research In Motion Limited (RIM) (Nasdaq: RIMM; TSX: RIM), a world leader

More information

Turkey s Largest Food Company

Turkey s Largest Food Company Turkey s Largest Food Company T h i r d Q u a r t e r & N i n e M o n t h s 2 0 1 3 F i n a n c i a l R e s u l t s N o v e m b e r 7, 2 0 1 3 Borsa Istanbul: ULKER ULKER.TI (Bloomberg) ULKER IS (Reuters)

More information

Financial Statement Consolidation

Financial Statement Consolidation Financial Statement Consolidation We will consolidate the previously completed worksheets in this financial plan. In order to complete this section of the plan, you must have already completed all of the

More information

Proposal to Reduce Opening Hours at the Revenues & Benefits Coventry Call Centre

Proposal to Reduce Opening Hours at the Revenues & Benefits Coventry Call Centre Proposal to Reduce Opening Hours at the Revenues & Benefits Coventry Call Centre Proposal To change the opening hours of the Revenues & Benefits Call Centre to 9am until 5pm Monday to Friday with effect

More information

First Quarter Fiscal Year 2016 Earnings Release and Conference Call. August 4, 2015

First Quarter Fiscal Year 2016 Earnings Release and Conference Call. August 4, 2015 Fiscal Year 2016 Earnings Release and Conference Call August 4, 2015 Forward-Looking Statements Forward-Looking Statements. This presentation contains forward-looking statements within the meaning of Section

More information

Health Care Worldwide

Health Care Worldwide Health Care Worldwide Credit Suisse Global Credit Products Conference September 18, 2014 Miami Credit Suisse Global Credit Products Conference, September 18, 2014 Copyright Page 1 Safe Harbor Statement

More information

Natalia Orlova, Chief Economist December 2004 Norlova@alfabank.ru +7 095 795 36 77

Natalia Orlova, Chief Economist December 2004 Norlova@alfabank.ru +7 095 795 36 77 New Environment for Refinancing in Russia Natalia Orlova, Chief Economist December 2004 Norlova@alfabank.ru +7 095 795 36 77 Excessive sterilization depressed liquidity Banking crisis stemmed from a decline

More information

SAP Debt Investor Presentation First Quarter 2014 Update Call Walldorf, Germany April 28, 2014

SAP Debt Investor Presentation First Quarter 2014 Update Call Walldorf, Germany April 28, 2014 SAP Debt Investor Presentation First Quarter 2014 Update Call Walldorf, Germany April 28, 2014 Safe Harbor Statement Any statements contained in this document that are not historical facts are forward-looking

More information

WWE. Key Performance Indicators. Calendar Years: 2010 2012 (Data shown is through March 31, 2012)

WWE. Key Performance Indicators. Calendar Years: 2010 2012 (Data shown is through March 31, 2012) WWE Key Performance Indicators Calendar Years: 21 212 (Data shown is through March 31, 212) April 25, 212 Forward Looking Statements This presentation contains forward looking statements pursuant to the

More information